Lifecore Biomedical, Inc. (LFCR)
(Delayed Data from NSDQ)
$7.87 USD
-0.06 (-0.76%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $7.86 -0.01 (-0.13%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth F Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, Lifecore Biomedical, Inc. has a market cap of $296.64M, which represents its share price of $7.93 multiplied by its outstanding shares number of 37.41M. As a small-cap company, LFCR's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
LFCR 7.87 -0.06(-0.76%)
Will LFCR be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for LFCR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LFCR
Lifecore Biomedical (LFCR) Soars 10.8%: Is Further Upside Left in the Stock?
Lifecore Biomedical (LFCR) Reports Q4 Loss, Tops Revenue Estimates
LFCR: What are Zacks experts saying now?
Zacks Private Portfolio Services
ImmunityBio (IBRX) Reports Q2 Loss, Tops Revenue Estimates
Lifecore Biomedical (LFCR) Reports Q3 Loss, Misses Revenue Estimates
Dare Bioscience, Inc. (DARE) Reports Q4 Loss, Misses Revenue Estimates
Other News for LFCR
LFCR forms Bearish Engulfing on September 19
Is LFCR showing upside potential? New Uptrend shows up after gaining 2.99%
The technical outlook for LFCR is unchanged after it falls 2.04% on September 17
Is LFCR getting ready to pop? Calm After Storm shows up after gaining 2.34%
20 Day Moving Average Support appears for LFCR after 2.13% move